##  [10 Key Steps to a Smooth First-Time Drug Registration in China](/index%2ephp/industry-videos/10-key-steps-to-a-smooth-first-time-drug-registration-in-china) 

Entering China’s rapidly expanding pharmaceutical market is a significant opportunity, but navigating the NMPA's expectations, data requirements, and approval timelines can be challenging without a clear roadmap.

In this short explainer video, we simplify the [10 essential steps](https://www.freyrsolutions.com/blog/10-step-guide-to-regulatory-approval-market-entry-in-china) that take you from development to successful market entry without delays or uncertainty.

If you’re:

- Unsure where to begin,
- Struggling with China-specific data or clinical expectations, or
- Concerned about long review cycles and complex submissions,

This guide breaks down the entire process into an easy-to-follow pathway for first-time entrants and global manufacturers expanding into China.

**Watch our quick guide to see how Freyr makes the journey faster, compliant, and hassle-free.**  
Start watching now and [connect with our experts](javascript:void(0)) to accelerate your China entry.